Bone grafting is replacement of damaged part of dental structure with the help of grafts such as autografts, allograft or xenograft. Patients with teeth missing need to undergo a dental implant procedure, however, if their jaw bone is thin or soft and is not able to hold the dental implant in its place, then they need to undergo a bone graft procedure. Synthetic substitutes such as Hydroxyapatite (HA) and Tricalcium Phosphate (TCP) are also been used in dental procedures. Various factors for dental deformities include gum disease, traumas, injuries, accidents, and genetic defects. Bone grafts offer various advantages such as preserving the structure and strength of the jaw bone, avoids the possibility of narrow and fragile jaw bone.
Market Dynamics
Bone graft materials are available in varieties such as allografts, xenografts, and synthetic substitutes and can be custom made according to the need of the patient, which makes it convenient for both, the physician and patient driving the growth of the market. Bone grafts are widely available from various sources such as from patients, from another donor, from animal sources, or are synthetically made. Furthermore, advancements in technology has led to development of synthetic graft options with better stability, sterility, and long life. These advancements have reduced surgical times along with post-operative pain and have improved healing time increasing adoption of these substitutes which has impacted the market. Development of biocompatible bone grafts such as B-OstiN and hydroxyapatite allografts and advent of different variants is a factor expected to fuel growth of the global dental bone graft substitutes market over the forecast period.
Key features of the study:
- This report provides an in-depth analysis of dental bone graft and substitutes market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global dental bone graft and substitutes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
- Key companies covered as a part of this study include Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., and LifeNet Health, Citagenix
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global dental bone graft and substitutes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the dental bone graft and substitutes market
Detailed Segmentation:
- Global Dental Bone Graft and Substitutes Market, By Product Type:
- Demineralized Bone Matrix (DBM)
- Allograft
- Xenograft
- Synthetic Bone Graft Substitutes
- Global Dental Bone Graft and Substitutes Market, By Material Type:
- Collagen
- Human Cell Source
- Animal Source
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Others
- Global Dental Bone Graft and Substitutes Market, By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Global Dental Bone Graft and Substitutes Market, By Geography:
- North America
- By Product Type:
- Demineralized Bone Matrix (DBM)
- Allograft
- Xenograft
- Synthetic Bone Graft Substitutes
- By Material Type:
- Collagen
- Human Cell Source
- Animal Source
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Others
- By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- By Country:
- Europe
- By Product Type:
- Demineralized Bone Matrix (DBM)
- Allograft
- Xenograft
- Synthetic Bone Graft Substitutes
- By Material Type:
- Collagen
- Human Cell Source
- Animal Source
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Others
- By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Demineralized Bone Matrix (DBM)
- Allograft
- Xenograft
- Synthetic Bone Graft Substitutes
- By Material Type:
- Collagen
- Human Cell Source
- Animal Source
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Others
- By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Product Type:
- Demineralized Bone Matrix (DBM)
- Allograft
- Xenograft
- Synthetic Bone Graft Substitutes
- By Material Type:
- Collagen
- Human Cell Source
- Animal Source
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Others
- By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- By Country:
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- By Product Type:
- Demineralized Bone Matrix (DBM)
- Allograft
- Xenograft
- Synthetic Bone Graft Substitutes
- By Material Type:
- Collagen
- Human Cell Source
- Animal Source
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Others
- By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Demineralized Bone Matrix (DBM)
- Allograft
- Xenograft
- Synthetic Bone Graft Substitutes
- By Material Type:
- Collagen
- Human Cell Source
- Animal Source
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Others
- By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- By Country:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Geistlich
- DENTSPLY International
- Zimmer Biomet
- Medtronic Plc.
- BioHorizons IPH, Inc.
- ACE Surgical Supply Company, Inc.
- RTI Surgical, Inc.
- LifeNet Health
- Citagenix
“*” marked represents similar segmentation in other categories in the respective section.
